Pakistani drugmaker wins second WHO prequalification for manufacturing site

Getz Pharma’s Astola manufacturing facility. — Reporter KARACHI: A Pakistani pharmaceutical company has secured World Health Organisation (WHO) prequalification for its Astola manufacturing facility on November 2, 2026, becoming its second production site to receive international recognition, its executive chairman Khalid Mahmood announced on Saturday night. Addressing physicians, surgeons and healthcare professionals gathered at the Astola…

Read Full News

First patient undergoes pioneering stem-cell treatment for Parkinson’s

China’s Health Ministry has ordered a stop to unapproved stem cell treatments. — Reuters A patient has undergone pioneering stem-cell therapy to treat Parkinson’s disease, the Japanese drugmaker behind the treatment said on Friday, in a world-first following its conditional approval in the country. Sumitomo Pharma’s treatment involves transplanting millions of induced Pluripotent Stem (iPS)…

Read Full News

Counterfeit flu vaccine stock seized in Lahore amid nationwide shortage

A representational image shows a syringe filled with a dose of a Covid-19 vaccine. — AFP/File Two suspects apprehended in Lahore raid: official. Urges public to buy vaccines from licensed pharmacies. Vaccines by multinational firms unavailable: official. LAHORE: Authorities in Lahore have seized a large stock of suspected counterfeit flu vaccines amid a nationwide shortage…

Read Full News

Karachi residents advised to mask up in crowded spaces amid surge in flu cases

Men wearing protective face masks walk amid the rush of people outside a market during an outbreak of the coronavirus disease (COVID-19) continues, in Karachi, Pakistan June 8, 2020. — Reuters Seasonal weather changes key factor behind rising flu cases. Children, elderly people and HIV patients face greater health risks. Medical experts recommend flu vaccination…

Read Full News

Drap directed to reassess drug pricing proposals, including flu vaccines

Representational image of a pharmacy. — Reuters 42 of 52 proposals concern new strengths of existing medicines. Lower import costs raise questions over influenza vaccine prices. Revised recommendations to go to federal cabinet for final approval. ISLAMABAD: Federal Minister for Climate Change Dr Musadik Malik said the Drug Regulatory Authority of Pakistan (Drap) had been…

Read Full News